Cases & Deals

Cellectis issues €22 million of Common Stock in private placement

Clients Cellectis

Jones Day advised Cellectis, a world leader in genome engineering listed on the Alternext market of NYSE Euronext Paris, in the issuance of €22 million (US$32.5 million) of Common Stock in a private placement.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.